Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer of Rocket Pharmaceuticals, sold 357 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.
Summary
- John Militello, an officer at Rocket Pharmaceuticals, sold 357 shares of common stock on May 20, 2025.
- The sale was executed at a price of $6.446 per share.
- The transaction was to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Militello directly owns 64,027 shares of Rocket Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (stock sale for tax obligations) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. The sale itself is unlikely to have a significant impact on the stock price, but it is important for transparency and regulatory compliance.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of the stock sale transaction. |
| 05/22/2025 | Date of signature for the Form 4 filing. |
Keywords
Rocket Pharmaceuticals, RCKT, John Militello, Form 4, insider trading, stock sale, tax obligations, Restricted Stock Units, RSUs, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.